Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-12-22 Sale | 2025-12-23 8:08 pm | OnKure Therapeutics Inc. | OKUR | Leverone Jason A. Chief Financial Officer | 302 | $2.9677 | $896 | 16,301 (Direct) | View |
| 2025-09-22 Sale | 2025-09-24 7:41 pm | OnKure Therapeutics Inc. | OKUR | Leverone Jason A. Chief Financial Officer | 303 | $2.6235 | $795 | 12,603 (Direct) | View |
| 2025-06-23 Sale | 2025-06-25 6:49 pm | OnKure Therapeutics Inc. | OKUR | Leverone Jason A. Chief Financial Officer | 303 | $2.3842 | $722 | 12,906 (Direct) | View |
| 2025-04-04 Sale | 2025-04-08 5:30 pm | OnKure Therapeutics Inc. | OKUR | Leverone Jason A. Chief Financial Officer | 3,122 | $2.9398 | $9,178 | 13,209 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-01-27 Option Award | 2025-01-29 8:35 pm | N/A 2035-01-26 | OnKure Therapeutics Inc. | OKUR | Leverone Jason A. Chief Financial Officer | 65,000 | $0 | 65,000 (Direct) | View |
| 2024-10-04 Option Award | 2024-10-08 7:26 pm | N/A 2032-01-10 | OnKure Therapeutics Inc. | OKUR | Leverone Jason A. Chief Financial Officer | 158,045 | $0 | 158,045 (Direct) | View |